Ketorolac for sickle cell pain crises in children
Treatments studied
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study tests a pain medicine called ketorolac for children with sickle cell disease who come to the emergency room or clinic with sudden, severe pain (a pain crisis). The goal is to see if ketorolac helps relieve pain safely and quickly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have sickle cell disease (any type).
- You are a child or teenager (pediatric patient).
- You are having sudden, severe pain from a sickle cell crisis.
- You have not taken an NSAID pain reliever (like ibuprofen or naproxen) in the last 6 hours.
- You do not have kidney problems, bleeding issues, or an allergy to NSAIDs.
- You do not have chronic pain or unstable vital signs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an intravenous medicine called L-citrulline for young people with sickle cell disease who are in the emergency department for a painful crisis (vaso-occlusive crisis). It aims to see if it can ease the pain and help you recover faster.
This trial tests if an intravenous medication called L-citrulline can help treat pain crises in children and young adults with sickle cell disease. Participants receive either the study drug or a placebo while in the hospital for a severe pain episode.
This trial compares different ways to manage sickle cell pain crises in the hospital, using a flexible 'platform' design to test combinations of pain medicines. It aims to find the safest and most effective approach to reduce pain and improve recovery.
This study tests whether a low-dose of ketamine (a pain medicine) can help children and young adults with sickle cell disease who are in a pain crisis. It aims to provide better pain relief while avoiding some side effects of standard painkillers.
This study looks at how children with sickle cell disease experience pain crises (severe pain episodes that often require hospital care). Researchers want to understand what happens during these crises, which might help improve care and treatment.
This trial tests whether a lower dose of the pain medicine ketorolac can safely control pain for people in the intensive care unit (ICU). If you are in the ICU and have pain, this study might help find a better way to treat it.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.